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ABSTRACT
Background: Regional anesthesia has been an excellent adjunct to anesthesia and has helped in
the fight against the opioid epidemic seen within the United States. Cancer patients undergoing
mastectomies can develop chronic pain as a result of not treating acute postoperative pain properly.
This chronic pain can lead to increased opioid consumption and opioid dependence. Regional
anesthesia, specifically the Pectoral Nerves II (PECS II) block, is a great technique that can help
patients undergoing mastectomies.
Objectives: The purpose of this study is to improve anesthesia provider knowledge on the value of
the PECS II Block for patients undergoing mastectomy surgery. A literature review addresses the
PICO question: “In patients undergoing general anesthesia for mastectomy, would the use of a
PECS II block compared to no block, reduce postoperative opioid consumption and acute
postoperative pain.” The educational framework provided to improve provider knowledge was
gathered through this literature review. Overall, this study aims to increase awareness of the PECS
II block for mastectomy patients to improve healthcare outcomes for this patient population.
Methodology: An online educational intervention which focuses on the benefits of the PECS II
Block for mastectomy patients will be administered to anesthesia providers. As part of this online
educational intervention, a pre- and post- assessment survey will be used to measure improvement
of provider knowledge.
Results: Overall, the statistical analysis between the pre-test and post-test showed there was an
overall improvement in provider knowledge following the education intervention. Additionally, the
likelihood of utilizing the PECS II block for mastectomy patients increased among providers.
Conclusions: The evidence illustrates how the PECS II block can be a safe and effective technique
that can help decrease opioid consumption as well as improve postoperative pain scores when
compared to using general anesthesia alone. More research must be done to determine the effect of
the PECS II block on chronic pain within this patient population
Keywords: Mastectomy, PECS II block, Regional anesthesia, Opioids, Breast cancer
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INTRODUCTION
Description of the Problem
The United States is presently battling an opioid epidemic. Approximately 11.5 million
Americans described misusing opioids in 2015.1 Surgery plays a vital role in patient exposure to
opioids. Approximately, 6-8% of opioid-naïve patients undergoing non-cancer-related surgery
develop ongoing opioid use and continue to refill prescriptions of opioids three to six months after
their surgery.2 For patients with cancer, that percentage increases significantly. In a study conducted
by Lee et al.,1 it was determined that 10% of opioid-naïve cancer patients undergoing curativeintent surgery developed ongoing opioid use.
Women affected by breast cancer are especially susceptible to opioid misuse. Breast cancer
affects approximately 12% of females in the United States. In 2019, there were an estimated
268,000 cases of newly diagnosed breast cancer among women.3 As of late, the survivability rate
for women with breast cancer has steadily increased. Caucasian women experienced a 16% increase
in survivability from 1977 to 2015, and African American women experienced a 21% increase
during the same period.4 This increase in survivability can be attributed to enhanced screening for
breast cancer and better treatment. Various treatment modalities are available to women with breast
cancer, such as Breast-Conserving Surgery (BCS), which removes the tumor and surrounding
border, chemotherapy, radiation, and mastectomy. In a recent study, patients who were eligible to
undergo BCS elected to undergo either unilateral or bilateral mastectomy due to various reasons
that included fear of cancer reoccurrence, unwillingness to undergo radiation, and need for
symmetry among both breasts.5
There is a significant amount of perioperative and postoperative pain associated with
mastectomies, and as with many other surgeries, opioids have become a mainstay in the treatment
of operative pain. Opioids are incredibly useful in treating acute pain but can have detrimental side
effects. As previously mentioned, opioids have a high incidence of being abused, especially among
oncology patients. Apart from abuse, there are many adverse side effects to consider when
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administering

and

prescribing

opioids.

For

example,

opioids

are

associated

with

immunosuppression and can also increase the chances of the tumor or cancerous cells returning.6
Furthermore, opioids can complicate perioperative and postoperative management by increasing
the patient's risk of experiencing falls, postoperative ileus, respiratory and central nervous system
depression, and hyperalgesia.7 Unfortunately, even with the use of opioids, some patients still
experience severe acute postoperative pain.
Approximately 20-30% of patients undergoing mastectomy experience chronic pain, which has
contributed to increased opioid consumption.8 Chronic pain following mastectomy can
dramatically and negatively affect women's lives by increasing healthcare costs, increasing feelings
of anxiety and depression, and decreasing their overall quality of life.8 A significant contributing
factor that can predict chronic pain following mastectomy is severe acute postoperative pain.
Poleshuck et al.9 determined that severe acute postoperative pain and preoperative psychosocial
distress were the main two determinants for developing chronic pain following mastectomy. It
stands to reason that if acute postoperative pain were controlled and managed appropriately, there
would be less chance that the patient would experience chronic pain later on in the recovery process.
Regional anesthesia, particularly the Pectoral Nerves II (PECS II) block, could be an excellent
modality that can effectively treat acute postoperative pain while avoiding the adverse side effects
of opioids.
Background
Blanco, Fajardo, and Parras (2012) were the first to describe this novel regional anesthesia
technique.10 The PECS II block aims to provide anesthesia to three sets of nerve groups that supply
the Pectoralis Major muscle (PMm), Pectoralis minor muscle (Pmm), and the Serratus anterior
muscle (SAM). By blocking these sets of nerves, the PECS II allows for sufficient axillary
clearance and can also provide anesthesia for the wide excisions that are necessary during
mastectomies.
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The first set of nerves blocked by the PECS II are the pectoral nerves that arise from the
brachial plexus. These nerves supply and innervate the pectoralis muscles and can be further
divided into the lateral pectoral nerve and medial pectoral nerve. The lateral pectoral nerve arises
from C5 through C7 and runs along a fascial plane in between the PMm and the Pmm. By coursing
through this fascial plane, the lateral pectoral nerve’s main purpose is to innervate the PMm. The
medial pectoral nerve runs underneath the Pmm. It crosses the Pmm and the clavipectoral fascia to
reach the lower third of the PMm.
The second set of nerves are the anterior divisions of the thoracic intercostal nerves from
T2 through T6. These nerves lie in a fascia between the pleura and posterior intercostal membrane
and can reach as far as the sternum. This set of nerves can also be further divided into the lateral
and anterior branches. The lateral branches pierce the intercostalis externi and the serratus anterior
muscle at the mid-axillary line to ultimately provide anterior and posterior terminal branches. The
anterior branches supply the medial aspect of the breast by crossing in front of the mammary artery
and pierce the intercostalis interni, intercostal membranes, and the PMm.
The last set of nerves include the long thoracic and thoracodorsal nerves. The long thoracic
nerve, also known as the serratus anterior nerve, arises from C5-C7. It enters the axilla behind the
brachial plexus and supplies the serratus anterior. It is important to note that during mastectomies,
the long thoracic nerve can become damaged and produce a winged scapula. The thoracodorsal
nerve is a branch of the posterior cord of the brachial plexus. This nerve runs beside the
thoracodorsal artery and innervates the latissimus dorsi in the posterior wall of the axilla.
In their study, Blanco et al. (2012) conducted this regional anesthetic technique under
ultrasound guidance using a two-injection approach. The patient should be in supine position with
the arm abducted 90 degrees. Once the patient is in position, the anesthetic provider should place
the transducer at the midclavicular level and angled infero-laterally. At this point, the axillary
artery, axillary vein and the second rib can be identified. The transducer should slide caudally until
the third rib is in view. Once the third rib is seen, the transducer should be rotated to allow for an
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in-plane needle approach from medial to lateral. The transducer is then moved towards the lateral
aspect of the Pmm until all three muscles can be identified. Using an in-plane approach, the needle
is inserted from medial to lateral until it reaches the fascial plane between the PMm and the Pmm.
Proper placement can be confirmed by hydro-dissection of the two muscles when local anesthetic
is injected. After proper separation, the needle is inserted further until it reaches the fascial plane
between the Pmm and the serratus anterior muscle. As with the first injection, proper placement
can be confirmed when local anesthetic is injected, and hydro-dissection occurs.
The PECS II block offers a simpler and safer regional anesthesia technique for
mastectomies when compared to other blocks such as the paravertebral block or epidural. Since the
PECS II block is a fascial plane block, the chances for intravascular local anesthetic injection is
dramatically decreased when compared to other regional anesthetic techniques. Furthermore, the
PECS II block is able to block medial and lateral pectoral nerves as well as long thoracic and
thoracodorsal nerves, whereas the other techniques are not able to.
Systematic Review Rationale
The purpose of this study is to determine anesthesia provider knowledge on the PECS II
block for treatment of postoperative pain in patients undergoing mastectomy surgery. A PowerPoint
presentation will be provided to Certified Registered Nurse Anesthetists (CRNAs) as part of an
educational intervention project. The goal of this project is to improve CRNA knowledge regarding
the PECS II block and increase the likelihood of utilizing this block to decrease postoperative pain
and opioid consumption.
Objectives of the Systematic Review
Increased pain in the acute postoperative period following mastectomy surgery has been
shown to be a significant factor in the development of chronic pain with this patient population. As
a result, these patients depend heavily on opioids to cope with their pain. Utilizing the PECS II
block as an anesthetic adjunct in these patients could substantially decrease the amount of pain
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experienced in the acute postoperative period, decrease opioid usage, and avoid the risks associated
with other regional anesthetic techniques
The first objective of this review is to determine if the PECS II block reduces acute
postoperative pain experienced by patients undergoing mastectomy surgery. The second objective
is to research if opioid usage decreases with the application of the PECS II block. Once PECS II
have been proven to decreased postoperative pain and opioid usage, a plan will be put into place to
include PECS II blocks in future ERAS protocols.
METHODOLOGY OF LITERATURE REVIEW
Search Strategy and Sources
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
checklist was used to organize and complete a search for the subject of this literature review.11 A
clinical question related to mastectomies and the PECS II block was formatted using the PICO
problem statement approach. Afterward, various databases, such as PubMed, Cumulative Index of
Nursing and Allied Health Literature (CINAHL), and MedLine (ProQuest), were searched to gather
information regarding the subject matter. Keywords and BOOLEAN operators included ‘pectoralis
nerve block AND mastectomy OR breast surgery’, ‘opioid consumption AND mastectomy or
breast surgery’, ‘postoperative pain OR chronic pain AND mastectomy or breast surgery’. Search
restrictions and filters included publication dates within the last five years, human subjects, English
language, female patients, and randomized controlled trials.
The PICO question for this paper is as follows: (P) In patients undergoing general
anesthesia for mastectomy, (I) would the use of a PECS II block (C) compared to no block, (O)
reduce postoperative opioid consumption and acute postoperative pain. This PICO question was
explicitly formulated to guide the literature review search as well as any specific keywords and
Boolean phrases. Through the systematic review, 89 articles were found. The MEDLINE database
provided 50 results, the PUBMED database provided 19 results, and lastly, the CINAHL database
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provided 20 results. After accounting for duplicate articles, there were 50 articles available for
appraisal. Literature review search strategy is represented in the PRISMA diagram in Appendix A.
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Table 1. Database Search Table
Database

PubMed

Boolean
Phrase

‘pectoralis nerve block AND
mastectomy OR breast
surgery’, ‘opioid
consumption AND
mastectomy or breast
surgery’, ‘postoperative pain
OR chronic pain AND
mastectomy or breast
surgery’

Search
Results

19

CINAHL
-

20

Medline
(ProQuest)
-

50

Study Selection and Screening of Evidence
The remaining 50 articles were reviewed in comparison to the PICO question. Of those 50
articles, 30 were excluded for not being full-text articles. Finally, various inclusion and exclusion
criteria were created based on the PICO question to refine the 20 available studies. Inclusion criteria
included mastectomy procedures, female gender, pectoralis nerve block II, and randomized
controlled trials. After reviewing the 20 articles and applying the inclusion/exclusion criteria, it was
determined that 7 of these articles appropriately answered the PICO question. Inclusion and
exclusion criteria used to select appropriate articles are represented in Table 2.

Table 2. Inclusion and Exclusion Conditions
Inclusion conditions
Type of study:
➢ Randomized controlled trials (RCT)
➢ Single or double-blinded study
➢ Prospective RCTs
➢ Publication within the last five years

Exclusion conditions
Type of study:
➢ Quasi-experimental
➢ Systematic reviews
➢ Publication date not within the
last five years
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Population:
➢ Human
➢ Female

Population:
➢ Nonhuman
➢ Male

Types of procedure:
➢ Mastectomy
➢ Radical Mastectomy

Types of procedure:
➢ Breast augmentation
➢ Breast Reconstruction

Intervention:
➢ The studies involved patients undergoing
mastectomies and receiving PECS II Block

Intervention:
➢ Pain management not related to
PECS II block

Outcomes:
➢ Decreased opioid consumption in the
postoperative period
➢ Improved postoperative pain rating scores

Outcomes:
➢ Any outcome than did not relate
to the patients receiving a PECS
II block

Collection, Analysis, and Data Items
The Johns Hopkins Nursing Evidence-based Practice (JHNEBP) tool was instrumental in
selecting the highest quality studies for this review. The JHNEBP has two rating scales to evaluate
the strength and quality of the research evidence.12 The first rating scale, which deals with the
strength of the evidence, has three levels. The first level is the strongest and comes from
experimental studies, randomized controlled trials (RCTs), or systematic reviews of RCTs that may
or may not have meta-analyses accompanying them.12 The second level corresponds with the
second strongest type of evidence and derives from evidence obtained from quasi-experimental
studies. Lastly, evidence from quantitative, non-experimental studies or systematic reviews that
include RCTs, quasi-experimental, and non-experimental is considered level three and the weakest
of the three groups.
The second rating scale of the JHNEBP considers the quality of the research evidence and
is divided into three grades. The first grade, A – high, determines that the research evidence is
consistent, has a sufficient sample size and definitive conclusions, amongst other things.12 The
second grade, B- good, determines that the research evidence has reasonable, consistent results, a
sufficient sample size, and relatively definitive conclusions. Lastly, the final grade, C- low or major
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flaw, determines that the research has little to no evidence, does not have consistent results, and
conclusions cannot be drawn based on the information.
Using the JHNEBP, this author selected the highest research studies available that were
most relevant to the PICO questions proposed earlier in this paper. Studies selected for this review
are illustrated in Appendix B.
RESULTS OF LITERATURE REVIEW
Study Selection
Eighty-nine articles were found when searching various databases. Of those eighty-nine
articles, fifty were duplicates, which left thirty-nine articles. After investigating the titles and
abstracts, thirty articles were eliminated, which left a total of twenty full-text articles to assess for
eligibility. Using the inclusion and exclusion criteria, thirteen full-text articles were excluded for
multiple reasons including: level 2 and 3 evidence, outcomes other than opioid consumption and
pain ratings, interventions other than the use of PECS II block, and language other than English.
Eventually, the study selection resulted in seven RCTs that were included in this systematic
qualitative review that answered the PICO question: “In patients undergoing general anesthesia for
mastectomy, would the use of a PECS II block compared to no block, reduce postoperative opioid
consumption and acute postoperative pain.” Table 3 provides a summary of all RCTs included in
the systematic review.
Table 3. Studies included in appraisal
Author (Year) & Level of
Evidence
Al Ja’bari et al.
(2019)
Level 1

Study, Participants,
Interventions, & Setting
50 ASA 1-3 pts, > 18 years old,
undergoing unilateral radical
mastectomy with or without
axillary node clearance under
General Anesthesia. Pts were
randomly allocated to either the
PECS II block group (25) or the
control group with only General
Anesthesia (25).

Findings in PECS II
Group (O Group)
Reduced 24h and 48h
postoperative morphine
dose (P=0.04)
Pain scores at 24h and
48h were similar for both
groups. (P=0.39 and
P=0.09 respectively)
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Neethu et al.
(2018)
Level 1

60 ASA 1-2 pts, 18-70 years old,
undergoing modified radical
mastectomy with or without
sentinel lymph node biopsy or
axillary lymph node dissection.
Pts were randomly allocated into
either the PECS group (30) or
control group with only GA (30)

Najeeb et al.
(2019)
Level 1

120 ASA 1-2 pts, > 18 years old,
undergoing elective modified
radical mastectomy under GA. 60
pts were randomly allocated into
the PECS group and 60 pts were
randomly allocated into the
control group with GA only

Senapathi et al.
(2019)
Level 1

50 ASA 1-2 pts, 16-65 years old,
undergoing unilateral modified
radical mastectomy. Patients
were randomly allocated to either
receive the PECS II block with
0.25% Bupivacaine (25) or
receive the PECS II block with
0.9% NaCl (25)

Versyck et al.
(2017)
Level 1

140 ASA 1-3 pts, 18-80 years old
undergoing mastectomy or
lumpectomy with sentinel or
axillary lymph node dissection.
Pts were randomized in a 1:1
ratio to either the PECS group
which received 0.25%
levobupivacaine or the control
group which received 0.9% NaCl
100 ASA 1-2, 18-65 years old
undergoing mastectomy requiring
axillary node dissection. Pts were
randomly allocated either into the
PECS group (50) or the control
group (50)
50 ASA 1-2 undergoing
unilateral modified radical
mastectomy. Pts were randomly
allocated into Group I which
underwent surgery only using GA
(25) or Group II which underwent

Khemka et al.
(2019)
Level 1

Kumar et al.
(2018)
Level 1

Decreased fentanyl
requirements in the PECS
group perioperative and
postoperatively (P<0.001)
for both respectively.
Visual Analog Scores
(VAS) for pain were also
decreased in the PECS
group
Decreased intraoperative
opioids (P=0.009)
Postoperative morphine
consumption to keep pain
scores less than 3 were
relatively equal between
both groups (P=1.0)
Decreased pain scores at
0hr, 6hr, 12hr, and 24 hr
(P<0.001)
Decreased intraoperative
opioid consumption
(P<0.001)
Decreased VAS Pain
scores at 3, 6, 12, and
24hrs (P<0.001)
Decreased postoperative
opioid consumption
(P<0.001)
Decreased Numerical
Rating Scale (NRS) pain
scores in the PACU
setting (P=0.048)
Decreased postoperative
opioid requirement
(P=0.037)

Decreased postoperative
opioid consumption
Decreased VAS pain
scores

Decrease total tramadol
consumption (P<0.0001)
Decreased VAS pain score
at rest (P<0.0001)
Decreased VAS pain score
on abduction (P<0.0001)

15
surgery using GA in conjunction
with the PECS II block (25)
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Study Characteristics
Altogether, the selected RCTs had a total of 380 participants who received the PECS II
block. The selected studies were published between 2017 to 2019 and in the English language.
Patient demographics were quite similar across all selected studies. All patients within the selected
RCTs underwent some form of mastectomy surgery with or without node involvement and were of
the female gender. Most of the studies’ patient demographics included patients with ASA levels of
1-2, with the exception being Al Ja’bari et al. and Versyck et al. who included ASA level 3 patients
in their respective studies.12,16
Methodology. Five RCTs conducted their study by comparing the PECS II block with
general anesthesia to the use of general anesthesia alone.13,14,15,18,19 Two of the studies compared the
PECS II block with a local anesthetic to the PECS II block with 0.9% normal saline. 16,17 While
most of the studies administered the PECS II block while the patients were under general
anesthesia, Kumar et al. administered the PECS II block in the preoperative setting.19 Three of the
studies performed the PECS II block with 0.25% bupivacaine, while administering 10 milliliters of
the local anesthetic between the Pmm and the PMm, and 20 milliliters between the Pmm and the
serratus anterior muscle.15,16,19 0.5% Ropivacaine was used for two of the studies with the same
amounts used for the injections.13,14 The last two studies utilized 0.25% levobupivacaine as their
local anesthetic, again with the same amount of local anesthetic injected into the fascial planes.17,18
Definitions and Findings of Outcomes
Six studies reported statistically significant differences in terms of the postoperative pain
experienced by the patients. Neethu et al. and Khemka et al. reported that Visual Analog Scores
(VAS) for pain were decreased in the PECS group immediately after surgery.14,18 Similarly, Najeeb
et al. found a statistically significant reduction immediately after surgery at 0hr, 6hr, 12hr, and 24
hr (P<0.001).15 Senapathi et al. discovered a statistically significant decrease in VAS pain scores at
3, 6, 12, and 24 hours after surgery (P 0.001).16 Versyck et al. found that pain scores on the
Numerical Rating Scale (NRS) were significantly lower in the PACU setting (P=0.048). 17 Kumar
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et al. found a significant decrease in VAS pain scores at rest and on abduction at all time intervals
(P<0.0001 for both). 19 However, one study reported no statistically significant difference in terms
of postoperative pain experienced by the patients. Al Ja’bari et al. reported that pain scores at 24h
and 48h were not significantly different between the two groups (P=0.39 and P=0.09
respectively).13
Six studies reported a decrease in opioid consumption. Al Ja’bari et al. reported a
significant reduction in 24h and 48h postoperative morphine dose (P=0.04). 13 Similarly, Neethu et
al. found a significant reduction in 24h fentanyl requirements in the PECS group perioperatively
(140.66 ± 31.80 µg) and postoperatively (438 ± 71.74 µg) when compared to the control group
perioperatively (218.33 ± 23.93 µg) and postoperatively (609 ± 53.00 µg, P = 0.001).14 Senapathi
et al. found a statistically significant reduction in the intraoperative and 24h postoperative opioid
consumption (P≤0.05).16 Versyck et al. and Khemka et al. also reported a significant reduction in
postoperative opioid requirement (P=0.037 and P<0.01, respectively).

17,18

Versyck et al. further

note that patients in the PECS group required significantly fewer interventions for postsurgical
opioid administration as compared to the patients in the control group (P=0.045). 17 Kumar et al.
also reported a significant reduction in 24h total tramadol consumption in the group who had
received general anesthesia along with ultrasound-guided PECS block (114.4 ± 4.63 mg) as
compared to the group who had received general anesthesia alone (402.88 ±74.22, P<0.0001). 19
However, one study showed no significant reduction in opioid consumption. In this regard, Najeeb
et al. found that although intraoperative opioid use significantly decreased (P=0.009), postoperative
morphine consumption to keep pain scores less than three was statistically non-significantly
different between both groups (P=1.0).15
Risk of Bias
As there can be many sources of bias in RCTs, Cochrane Handbook Collaboration’s Risk
of Bias tool was applied to evaluate bias in all seven studies included in this systematic review. 20
All seven studies utilized a random sequence generation and therefor had a low risk of selection
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bias. All the authors except Najeeb et al. and Versyck et al. discussed their concealment method
including sequence-generated codes, using a statistical department to allocate randomly, or utilizing
sequentially numbered, opaque, sealed envelopes.13,14,16,18,19
Performance bias was also a concern that is mentioned in Cochrane’s tool. Five of the
studies included in this systematic review were single-blinded meaning only the participants did
not know which treatment they were receiving.13,14,15,18,19 Two of the studies were double-blinded
meaning neither the participants not the clinicians knew which treatment they were receiving.16,17
Lastly, attrition bias was assessed as part of Cochrane’s tool. Only the authors of Versyck
et al.’s study discussed exclusion reasons of participants for a protocol violation, which placed this
particular study at high risk of attrition bias and must be considered for bias because of incomplete
data collection.17 Although none of the studies stated the possibility of selective outcome reporting,
reporting bias is still a concern and may have occurred in the studies.
DISCUSSION OF LITERATURE REVIEW
Summary of Evidence
There were two main outcomes evaluated for this review: postoperative pain experienced
by the patient and opioid consumption. As far as postoperative pain, four of the studies employed
a visual analog scale (VAS) to assess pain experienced by the patients.14,15,18,19 Three of the studies
instead used a Numerical Rating Scale (NRS) to assess pain in the postoperative period. 13,16,17 Six
of the seven studies concluded that the use of the PECS II block resulted in improved pain scores
when compared to the control group. For opioid consumption, six of the seven studies concluded
that patients who received the PECS II block required a decreased amount of opioids whether in
the perioperative or postoperative setting.
Limitations of the Systematic Review
One of the strengths of this systematic review is that the studies included in this review had
a similar study design. They were all randomized controlled trials representing a high level of
evidence. Another strength is that the objective of the systematic review, the inclusion and
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exclusion criteria, and the flow chart is clearly presented, which could help in replicating the review
by other reviewers.
One of the limitations of this systematic review is that the studies included in this review
considered different opioids, including tramadol, morphine, and fentanyl, thereby showing
heterogeneity in the treatment given to the participants. Moreover, the sample size showed some
variation in the studies, though the variation is not large. In some of the studies, such as that
conducted by Al Ja’bari et al., Neethu et al., Senapathi et al., and Kumar et al., the sample size is
small that could affect the statistical significance of the findings.13,14,16,19 Another limitation is that
not all studies considered the blinding of the researchers or experts or participants, such as that
conducted by Khemka et al. and Kumar et al. that could be associated with an influence on the pain
management during and after the surgery, and could be linked to the biasedness of the findings. 18,19
Al Ja’bari et al. has not presented any information regarding blinding in their research, so
biasedness could not be assessed for this finding. 13
Recommendations for current practice
The findings of this review show that general anesthesia along with ultrasound-guided
PECS block could be recommended in reducing opioid requirements during and after surgery
involving breast cancer. The use of ultrasound-guided blocks could also allow the real-time
visualization of the placement of the needle, thereby reducing the chances of further complications
by reducing the risk of the needle traversing the tumor. Moreover, in clinical practice, the use of
PECS block offers several other advantages, such as those related to post-operative pain relief and
overall patient satisfaction. The use of PECS block is also recommended as it has also been found
helpful in the quick recovery of patients and reducing their hospital stay.
Apart from its advantages, it is also important to consider that ultrasound-guided PECS
block is not only a simpler technique, but it is also better as compared to several other techniques,
such as paravertebral block and thoracic epidural analgesia after breast surgery. Therefore, this
technique could be recommended in situations where all of these techniques could be used.
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Recommendations of Future Research
In the future, large-scale randomized controlled trials could be conducted that would also
positively affect the statistical significance of the findings. Furthermore, the studies, in the future,
must have adequate power so that the larger sample size along with adequate power could help in
increasing the chances of applying the conclusions to a larger population. Moreover, the blinding
of the researchers, experts, and participants needs to be ensured. Along with the blinding, the
allocation concealment (a process in which nobody knows whether the next eligible participant will
be placed in the treatment group or the control group) must also be ensured so that the chances of
bias can be reduced in the future studies. Researchers may also explore the differences between
different types of opioids in association with the study of PECS block. For example, the differences
between morphine and fentanyl or the differences between tramadol and any other opioid in
association with the intervention of ultrasound-guided PECS block could be studied.
METHODOLOGY OF QUALITY IMPROVEMENT PROJECT
Settings and Participants
The setting for this project will be through an online survey and an educational PowerPoint
module with the members of the Anesthesia Department from Miami Beach Anesthesiology
Associates (MBAA) at Mount Sinai Medical Center in Miami Beach, Florida. The study will be
comprised of anesthesia providers such as CRNAs and Anesthesiologists. Participation will be
based on individuals who were invited to take part in the survey through an email list provided by
MBAA and will be asked to provide feedback based on their experience with the educational
module. The anticipated sample size will be between 5-15 participants.
Description of Approach and Project Procedures
The primary methodology of the proposed project is to administer an online educational
module to anesthesia providers that focuses on administering the PECS II block to patients
undergoing mastectomy surgery to decrease postoperative pain and opioid consumption. The
project will be administered in three stages. The first stage will consist of an online pre-assessment
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test that will assess the anesthesia providers knowledge regarding breast cancer, mastectomies, and
the PECS II block.
The second stage will include an educational PowerPoint with information regarding the
administration of the PECS II Block and its effect on the amount of pain experienced by patients
after mastectomy surgery as well as the amount of opioids needed for peri- and post- operative pain
management. Providing this education to anesthesia providers is essential to improving outcomes
and experiences of patients undergoing mastectomy surgery. Recent studies have shown that the
use of the PECS II block as an adjunct for mastectomy surgery has decreased the amount of pain
experienced by patients as well as the amount of opioids required for peri- and post- operative pain
management. The third and final stage will include a post-assessment survey that will measure the
amount of learning experienced by the anesthesia providers as well as their perception of the
educational presentation. This information will provide immediate feedback concerning the impact
of the educational intervention and will assist in determining how to further provide information
on the benefits of the PECS II block for mastectomy surgery.
Protection of Human Subjects
Providers who participated in this survey remained unidentified and the data was secured
using a randomized number sequence allocation. The data collected from both surveys were
protected on a laptop secured with a password, which ensured the safety of the data. There are
minimal perceived risks to the study as it only requires the time spent by each anesthesia provider
in the educational intervention.
Data Collection
The primary means of data collection will include a pre-assessment and post-assessment
survey to determine the effects of the educational intervention. Both surveys will be done through
Qualtrics and will consist of approximately ten questions which focus on knowledge and current
practice. The pre-assessment survey will assess knowledge and current perceptions on the
educational material, while the post-assessment survey will determine if the participants gained

22
knowledge from the intervention. The instrument reliability and validity will be measured in
accordance with the intervention provided and its effectiveness for the participants. The data
collected will be confidential, and no subject identifiers will be recorded during any component of
the study.

Data Management and Analysis Plan
The DNP student, who is a co-investigator for this project, will be responsible for
administering the survey. The investigator conducted the statistics that will be utilized to evaluate,
compare, and analyze the pre-assessment and post assessment. Each question will be compared and
analyzed, and the responses recorded to identify the knowledge base before and after the
intervention was provided. The outcome of the educational intervention will be measured solely on
the results of the pre- and post-test survey questions. Through statistical analysis, the study results
will likely identify patterns that will be used to determine the effectiveness of educational
intervention.
RESULTS OF QUALITY IMPROVEMENT PROJECT
Pre- and Post- Test Participant Demographics
The demographics are shown in Table 4 below.
Table 4.
Participant Demographics
Demographics
Total Participants
Gender
Male
Female
Age
<18 yr
18 – 29 yr
30 – 49yr
> 50 yr
Ethnicity

N (%)
12 (100%)
7 (60%)
5 (40%)
0 (0%)
4 (30%)
8 (70%)
0 (0%)
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Hispanic
Caucasian
African American
Asian/Pacific-Islander
Other
Education
Masters
Doctorate
Years of CRNA Practice
0 – 2 yr
2 – 5 yr
5 – 10 yr
10 – 20 yr
> 20 yr

1 (8%)
9 (75%)
1 (8%)
1 (8%)
0 (%)
2 (16%)
10 (84%)
3 (25%)
7 (58%)
1 (8%)
1 (8%)
0 (%)

There were 12 participants in the pre- and post- test demographics. Most of the participants
were male (n=7, 60%), as opposed to female (n=5, 40%). More than half of the participants were
between the ages of 30 – 49 years old (n=8, 70%), and the remaining participants were between the
ages of 18 – 29 years old (n=4, 30%). The following ethnicities were represented: Caucasian (n=9,
75%), African American (n=1, 8%), Hispanic (n=1, 8%), and Asian/Pacific-Islander (n=1, 8%).
Information was obtained about the participant’s level of education, and it was found that the
majority had a doctorate’s degree (n=10, 84%) and only a few had a master’s degree (n=2, 16%).
Participants were also questioned about their years of practice as a certified registered anesthetist
(CRNA) and a mix of experience was found: 0 – 2 years (n=3, 25%), 2 – 5 years (n=7, 58%), 5 –
10 years (n=1, 8%), and 10 – 20 years (n=1, 8%).
Pre- and Post-test Knowledge Comparison About Breast Cancer and Mastectomy Surgery
Table 5
Questions
What percentage of cancer patients undergoing curative-intent
surgery develop chronic opioid use?
Breast cancer affects approximately what percentage of females
within the United States?

Pretest
17%

Posttest
83%

Difference
66%

50%

100%

50%
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Approximately what percentage of mastectomy patients
experience chronic pain that often leads to chronic opioid use?

17%

83%

66%

Which significant contributing factor can predict chronic pain
following mastectomy surgery?

67%

75%

8%

In table 5, knowledge regarding breast cancer and mastectomy surgery is compared
between the pre-test and post-test based on the percentage of participants that answered the question
correctly. Overall, the higher scores in the post test questions reflect that the knowledge of the
participants regarding breast cancer and mastectomy surgery did improve after watching the
PowerPoint presentation. The question regarding contributing factors for developing chronic pain
had the lowest percentage increase (n=1, 8%), with only one more person answering correctly in
the post test. However, there was a 66% increase in participants that were able to correctly identify
percentage of patients that develop chronic opioid use and chronic pain. Lastly, there was an
increase of 50% in participants that were able to identify the percentage of females affected by
breast cancer.
Pre- and Post-test Knowledge and Perspective Comparison of PECS II Block
Table 6
Questions

Pretest
75%

Posttest
100%

Difference
25%

The PECS II Block involves how many fascial planes?

66%

100%

34%

When compared to a paravertebral block or an epidural, the
PECS II block offers what advantages?

83%

100%

17%

How effective is the PECS II block in reducing acute
postoperative pain and opioid consumption

66%

100%

34%

How likely are you to use alternative methods to decrease
postoperative acute pain in patients undergoing mastectomy
surgery?

83%

100%

17%

How likely are you to recommend the PECS II block as an
anesthetic adjunct for women undergoing mastectomy surgery?

83%

100%

17%

The PECS II block aims to block the nerves that supply which
muscle(s)?
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In table 5, knowledge regarding the PECS II block is represented in the first three questions
and is compared between the pre-test and post-test based on the percentage of participants that
answered the question correctly. Overall, knowledge regarding the PECS II block improved after
watching the PowerPoint presentation, as this is reflected by the increase in post-test scores. The
question regarding how many fascial planes are involved in the PECS II block experienced the
highest difference in post-test scores (n=4, 34%), followed by the question regarding the nerves
involved with the PECS II block (n=3, 25%), and lastly the question regarding advantages over
other nerve blocks (n=1, 17%).
The last three questions dealt with the practitioner’s perceptions of the PECS II block. As
seen in table 5 overall perception of the PECS II block increased among the anesthesia providers.
The biggest difference is seen in the question regarding the effectiveness of the PECS II block
where there was an increase of 34% (n=4). Both questions regarding including the PECS II block
in current practice also saw an increase of 17% (n=2).
DISCUSSION OF QUALITY IMPROVEMENT PROJECT
Limitations
Limitations of the study include a small sample size; the survey was emailed to the MBAA
email list which was composed of 31 emails but only 12 participants completed the study. A larger
sample size could have strengthened the results of the study and provide a sample population that
is indicative of the anesthesia providers at Mount Sinai Medical Center. Also, the survey link which
contained both surveys and the PowerPoint presentation was only available online for two weeks,
perhaps increasing the time allotted to review the material and surveys could have increased the
number of responses. Lastly, the project was implemented completely online hindering its delivery
by other methods.
Future Implications
The outcomes of this study are important in determining strategies available to participants
that will improve knowledge and potentially change practice to improve outcomes in patients
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undergoing mastectomy surgery. According to the data collected, the educational intervention
provided was effective in increasing anesthesia provider knowledge on the PECS II block and its
role in decreasing acute postoperative pain and opioid consumption. Furthermore, there was an
increase in the likelihood of utilizing the PECS II block for this patient population. The results of
this study can be applied to a wider audience of certified registered nurse anesthetists.
CONCLUSION
Patient’s undergoing mastectomy surgery experience a great amount of pain which can
lead to increased opioid consumption and acute postoperative pain scores. As healthcare providers,
our first priority is to our patients and to develop plans that set them on the best path to recovery.
With mastectomy surgery being so painful, it is prudent to include modalities other than opioids to
help decrease pain. As presented in this paper, the PECS II block is an excellent alternative or
adjunct that can both decrease opioid consumption and postoperative pain. The quality
improvement project which included an educational module regarding the PECS II block showed
that anesthesia providers are willing to include this regional technique in their plans for patients
undergoing mastectomy surgery.
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A. Al Ja’bari, M. Robertson, K. El-Boghdadly and E. Albrecht. A
randomised controlled trial of the pectoral nerves -2 (PECS-2) block for
radical mastectomy13
Prospective, randomized control trial. Researchers utilized a computergenerated randomisation table to allocate a total of 50 women in a 1:1 ratio,
in blocks of 10, to PECS-2 block or no block.
Sample: 50 total patients, n=25 experimental group patients, n=25 control
group patients. ASA I – III females > 18y. Setting: Lausanne University
Hospital
The primary outcome was cumulative morphine dose at 24 postoperative
hours. Secondary outcomes were cumulative morphine doses at 2 and 48
postoperative hours, morphine consumption at 24–48 postoperative hours,
interval pain scores at rest at 2, 24 and 48 postoperative hours, rates of
nausea, vomiting and pruritus at 24 and 48 postoperative hours and
participant satisfaction (VAS, 0–10) at 48 postoperative hours
Researchers used a visual analogue scale (VAS) (0–10) to measure
immediate postoperative pain and injected morphine 1–2 mg i.v. for pain >
3 or in response to direct request.
Pectoral nerves-2 block reduced mean (SD) 24-h postoperative morphine
dose from 9.7 (8.9) mg to 5.0 (5.4) mg and 48-h morphine dose from 12.8
(12.5) mg to 6.0 (6.5). The 24–48-h interval morphine consumption was
0.8 (1.7) mg and 3.2 (4.5) mg with and without block, respectively
Patients in the experimental group experienced a decrease in postoperative
morphine consumption when compared to the control group. Secondary
outcomes were not statistically different between the two groups.
Researchers found that the PECS-2 block with ropivacaine 0.5% reduced
cumulative 24 h and 48 h morphine dose after radical mastectomy, when
compared with no block
Strengths: Level I Prospective, randomized control trial. Weaknesses:
Small sample size in a university hospital that may limit generizability of
results. Feasibility of use: Authors successfully demonstrated that PECS II
block is an effective adjunct to general anesthesia, and doing so reduces
postoperative opioid consumption
This research study addresses the decreased opioid consumption variable
addressed within the PICO question

Neethu M , Ravinder Kumar Pandey, Ankur Sharma, Vanlalnghaka
Darlong, Jyotsna Punj, Renu Sinha, Preet Mohinder Singh, Nandini
Hamshi, Rakesh Garg, Chandralekha Chandralekha, Anurag Srivastava.
Pectoral nerve blocks to improve analgesia after breast cancer surgery: A
prospective, randomized and controlled trial14
Prospective, randomized, control trial. Patients were randomized into two
groups consisting of 30 patients in each group. The first group was the
PECS (P) group and the second group was the control (C) group. Group P,
patients received both general anesthesia and ultrasound guided combined
pectoral nerve blocks (PECS I and II). In group C, patients received only
general anesthesia.
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Sample: 60 total patients. n=30 experimental group patients. n=30 control
group patients. ASA I-II females aged18-70; Setting: Operating rooms in a
tertiary care hospital of Northern India
The primary outcome of this study was to evaluate the analgesic efficacy of
combined PECS I and PECS II block with GA in these patients as
compared to conventional group (only GA). The secondary outcomes were
to find out time to first analgesic request (VAS N3) in post-operative
period, limitation of shoulder movement on the operative site at 4 h, 5 h,6 h
and 24 h after surgery, incidence of post- operative nausea and vomiting
(PONV) and patient's satisfaction with postoperative analgesia.
The primary outcome was measured by amount of fentanyl requirement in
the intraoperative and post- operative period (24 h)
The mean total fentanyl consumption in the intraoperative period in group P
was 140.66 ± 31.80 μg and in group C was 218.33 ± 23.93 μg. The VAS
scores at rest and movement were significantly less in group P at immediate
post-operative period, 30 min, 1 h, 2 h and 4 h in the post-operative period.
VAS scores at rest and movement were not statistically significant in all
other study periods between the groups
Less fentanyl requirement was observed in the P group during
intraoperative and post-operative period up to 24 h. The time to first
analgesic requirement was also more in P group in comparison to C group
during post-operative period. Less limitation of shoulder movement on the
operative site at 4 h and 5 h after surgery in P group in comparison to C
group. Patients in group P had a better satisfaction with postoperative
analgesia than C group.
Adult women undergoing modified radical mastectomy with a PECS II
block as compared to the conventional group experienced a decrease in the
total amount of fentanyl required in the intraoperative and post- operative
period, decreased pain rating scales in the postoperative period which led to
an increased duration for time to first analgesic requirement, and
experienced less limitation of shoulder movement (pain free mobilization)
on the operative site at 4 h and 5 h after surgery.
Strength: Level 1 RCT, excellent data collection that adds value to the
study’s conclusions. Weakness: small sample size at one clinical site, not
able to check success of the block as it was done after induction. Feasability
of use: These authors provided more than enough information to warrant
the use of PECS II block as an adjunct to general anesthesia for patients
undergoing mastectomies.
The theme of this research study parallels the PICO question set forth in
this paper. The authors were able to successfully demonstrate that patients
who received a PECS II block had a decreased opioid consumption
postoperatively and decrease Visual Analog Scale (VAS) scores.

Hammad Nabeel Najeeb, Syed Raza Mehdi, Athar Mukhtar Siddiqui and
Syeda Kiran Batool. Pectoral Nerves I, II and Serratus Plane Blocks in
Multimodal Analgesia for Mastectomy: A Randomised Clinical Trial15
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Prospective, randomized control trial. Patients were then randomly assigned
to one of the 2 groups using a predetermined random 1:1 sequence. Group
A (PECS block group) received pectoral nerve I, II and serratus plane block
and general anesthesia (n=60) and Group B (Control group) received
general anesthesia alone (n=60) along with standard perioperative analgesia
which included paracetamol, non-steroidal anti-inflammatory medication
and morphine intravenously.
Sample: 120 total patients. n=60 experimental group patients, n=60 control
group patients. Setting: Department of Anesthesiology, Shaukat Khanum
Memorial Cancer Hospital Lahore (SKMCH)
Primary objective was to assess pain score in first 24 hours in PECS block
group undergoing mastectomy; secondary objective was to observe opioid
and antiemetic consumption in the postoperative period

Registered nurses, that were blinded to the patient grouping, assessed the
postoperative pain using the Numerical Pain Rating Scale at the time of
arrival at PACU (0 minute) and then at 30 minutes after surgery and at
discharge from PACU. Pain score was further assessed at the surgical floor
at 6 hours, 12 hours and 24 hours post-surgery by the ward nurses who
were trained in pain assessment and NPRS
Patients who received the PECS block had an average pain score of 1 in the
immediate postoperative period whereas the control group had an average
2.4 in the same time period. Furthermore, at 6hrs postop, the PECS group
had an average score of 0.8, whereas the control group had an average of
2.2 in the same time period
Patients in the PECS experienced significantly lower NPRS scores when
compared to the control group. Patients in the PECS group also consumed
less opioids in the postoperative period when compared to the control group
The authors concluded that the PECS block produced better quality
analgesia when combined with general anesthesia than with general
anesthesia alone.
Strengths: Level I RCT, generous sample size, authors were able to
successfully demonstrate how PECS II block decreases NPRS scores
Weakness: As with other studies, the level or density of the block could not
be determined as it was done under anesthesia. Feasibility of use: This
study not only showed the efficacy of PECS II block but also showed how
it led to decreased opioid consumption which in turn led to decreased
Postoperative nausea and vomiting and therefore less use of ondansetron.
This study adequately addresses the main concepts in the aforementioned
PICO question. The authors were able to demonstrate how the PECS II
block sufficiently decreases opioid consumption and acute postoperative
pain

Senapathi, Tjokorda Gde Agung; Widnyana, I. Made Gede; Aribawa, I.
Gusti; Ngurah Mahaalit; Jaya, A. A. Gde Putra Semara; Junaedi, I. Made
Darma. Combined ultrasound-guided Pecs II block and general anesthesia
are effective for reducing pain from modified radical mastectomy16
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Double-blind RCT. Patients were split into two groups: PECS groups or
control group. The PECS group received the PECS block with 0.25%
bupivacaine. The control group received the PECS block with 0.9% NaCl.
Sample: 50 total patients. n=25 experimental group patients. n=25 control
group patients. ASA I-II, ages 16-65 years Setting: Sanglah Hospital
The independent variable in this study is the is the PECS II block either
with 0.25% bupivacaine or 0.9% NaCl. The dependent variables are
intraoperative opioid consumption, postoperative pain, and postoperative
opioid consumption.
Postoperative pain was measured with the VAS score. Intraoperative opioid
consumption was measured in terms of mcg of fentanyl. Postoperative
opioid consumption was measured in terms of mg of morphine
Intraoperative opioid consumption was 125 mcg of fentanyl for the Pecs
group and 250 mcg of fentanyl for the control group. VAS scores at 3 hours
postoperatively were 0.8 for the PECS group and 2.8 for the control group.
Postoperative opioid consumption was 3 mg of morphine for the PECS
group and 11 mg of morphine for the control group
The PECS group did significantly better than the control group in all
aspects of the dependent variables
The authors of this study concluded that the PECS II block in conjunction
with general anesthesia is an effective modality in reducing intra and postoperative pain for patients undergoing mastectomies
Strengths: Level I double-blinded RCT, effective data retrieval supporting
the use of PECS II block Weakness: Small sample size Feasibility of use:
The authors were able to explain the advantages of the PECS block as
opposed to other regional techniques
This study was able to support both aspects of the PICO question proposed
earlier in this paper.
Barbara Versyck, MD, Geert-Jan van Geffen, MD, PhD, Patrick Van
Houwe, MD. Prospective double-blind randomized placebo-controlled
clinical trial of the pectoral nerves (Pecs) block type II 17
Double-blind RCT. Patients were split into two groups: PECS groups or
control group. The PECS group received the PECS block with 0.25%
levobupivacaine. The control group received the PECS block with 0.9%
NaCl.
Sample: 140 total patients. n=70 experimental group patients. n=70 control
group patients. ASA I-III females, ages 18 – 80 years with tumor stage 1-3
breast cancer undergoing mastectomy. Setting: GZA Ziekenhuizen Campus
Sint-Augustinus hospital in Belgium
Independent variable in this study is the PECS II block with either 0.25%
levobupivacaine or 0.9% NaCl. Dependent variables include postoperative
pain and postoperative opioid consumption

Postoperative pain was measured using the NPRS system. Postoperative
opioid consumption was measured in oral morphine equivalents (OME)
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Patients in the PECS group averaged 9 mg of OME in order to achieve a
NPRS of less than 3 while patients in the control group averaged 15 mg of
OME to achieve the same score.
Patients in the PECS group experienced less pain than those in the control
group in the immediate postoperative period. As a result, the PECS group
had a lower consumption of OME in thee postoperative period when
compared to the control group
The authors of this study determined that the PECS II block results in lower
pain levels and ultimately reduces postoperative opioid consumption during
the PACU stay
Strengths: Level I Double-blinded RCT. Impressive sample size.
Weaknesses: Due to a protocol violation by one anesthesiologist, some
participants had to be excluded from data analysis
This study adequately addressed both aspects of the PICO question.
Rakhi Khemka, Arunangshu Chakrborty, Sanjit Agrawal1, Rosina Ahmed.
Is COMBIPECS the answer to perioperative analgesia for breast surgery?
A double blinded randomized controlled trial18
Double-blinded randomized control trial. Patients were randomized into a
PECS experimental group and a control group. The PECS group received
the PECS II block whereas the control group underwent surgery with no
PECS block
Sample: 100 total patients. n=50 experimental group patients. n=50 control
group patients. ASA I-II females ages 18-65 years. Setting: Tata Medical
Center, India
The independent variable in this study is the administration of the PECS II
block. Dependent variables in this study include postoperative pain and
postoperative opioid consumption.

Postoperative pain was measured using the VAS scale, while postoperative
opioid consumption was measured by cumulative intravenous morphine
consumption from patient-controlled analgesia (PCA) pump.
Patients in the PEC group reported an average VAS score of 0.96 in the
immediate postoperative period whereas patients in the control group
reported an average of 2.2. Patients in the PEC group used an average of
0.4 mg of morphine on the PCA pump in the immediate postoperative
period whereas patients in the control group used an average of 2.42 mg of
morphine.
Patients in the PEC group experienced better VAS scores as well as
decreased postoperative consumption.
The authors of this study determined that the PECS II block in conjuction
with general anesthesia effectively reduced perioperative opioid
consumption and VAS scores.
Strengths: Level I double-blinded RCT. The authors provide a new manner
in completing the PECS II block with a sole injection. Weaknesses: The
anesthetists could not be blinded to group allocation.
This study further solidifies the two point proposed in the PICO question
regarding opioid consumption and reducing acute postoperative pain.
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Satish Kumar, Deepali Goel, Santosh Kumar Sharma, Shahbaz Ahmad,
Priyanka Dwivedi, Narendra Deo, Raka Rani. A randomised controlled
study of the post‑operative analgesic efficacy of ultrasound‑guided pectoral
nerve block in the first 24 h after modified radical mastectomy19
Prospective, randomized control trial. Patients were randomized into two
groups. Group I underwent mastectomy under general anesthesia alone.
Group II underwent mastectomy under general anesthesia combined with
PECS II block.
Sample: 50 total patients. n=25 experimental group patients. n=25 control
group patients. ASA I-II females undergoing mastectomy surgery for breast
cancer. Setting: Tertiary care teaching hospital in India
The independent variable in this study is the use of a PECS II block for
pain management. Dependent variables include patient-reported pain
intensity and postoperative opioid consumption
Patient’s reported postoperative pain using the VAS system. Postoperative
opioid consumption was reported as 24-h tramadol consumption
VAS scores for group I averaged 3-4 in the postoperative period whereas
the VAS scored for group II averaged 1-2.
Group II patients who received the PECS II block experienced significantly
lower VAS scores as well as decreased opioid consumption when
compared to group I
The authors concluded that the PECS block offers superior advantages for
the treatment of postoperative pain management.
Strengths: Level I RCT. The PECS block was done before induction and so
researchers were able to determine the density of the block. Weaknesses:
Small sample size.
This study supports the two variables proposed in the PICO question
regarding opioid consumption and postoperative pain.
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